Neurotech

Other Neurotech: The Odd Ones Out In Volume I of this series on Consumer Neurotech, we established a framework for thinking about Consumer Neurotechnologies and their value propositions. In Volume II, we discussed neurotechnologies that have the value proposition of Control (or,…

Neurotech for Brain Modulation In Volume I of this series on Consumer Neurotech, we established a framework for thinking about Consumer Neurotechnologies and their value propositions. In Volume II, we discussed neurotechnologies that have the value proposition of Control (or, using our…

Neurotech for Feedback In Volume I of this series on Consumer Neurotech, we established a framework for thinking about Consumer Neurotechnologies and their value propositions. In Volume II, we discussed neurotechnologies that have the value proposition of Control (or, using our taxonomy…

Neurotech for Control In the first part of this series on Consumer Neurotech, we established a framework for thinking about Consumer Neurotechnologies and their value propositions. With the initial groundwork laid, we can finally dig into the technologies themselves. Here,…

We pride ourselves on contrarian curiosity. When that curiosity leads us to new conclusions, we change our minds. As part of that exploration, the areas that we find most interesting evolve over time. What was once frontier eventually becomes commonplace.…

At Loup Ventures, we’ve been spending more and more time researching and reflecting on how everyday technology will leverage the human brain to provide value to users. We call this subject consumer neurotechnology, and we want to share some of…

Jo Jo Platt is the President and Cofounder of Platt & Associates, Inc., and Strategic Relations Consultant for the Feinstein Institute for Medical Research. Top 3 Takeaways Bioelectronic Medicine treatments have a number of distinct advantages over drug-based treatments from…

Dr. E.J. Chichilnisky is a Professor of Neurosurgery at Stanford University, where he and his lab are developing a retinal prosthesis. E.J. completed his B.S. in Mathematics at Princeton University, and his Masters in Mathematics and Ph.D. in Neuroscience at…

Dr. Matt Angle is the CEO and founder of Paradromics, a brain-computer interface company developing high-bandwidth implantable neural interfaces. Matt completed his B.S. in Biology at Carnegie Melon University and his Ph.D. in Neuroscience at the Max Planck Institute. Top…

Bioelectronic medicine is like a medical supplies aircraft flying close to the surface of the sea: significant promise, and under the radar. As a field, bioelectronic medicine (BEM) is a paradigm shift from existing medicine: instead of treating patients by…

Dr. Ramses Alcaide is the CEO and Founder of Neurable, a Loup Ventures portfolio company focused on non-invasive BCI. Ramses earned his undergraduate degree at the University of Washington in Electrical and Electronics Engineering and a Ph.D. in Neuroscience from the…

Brave early adopters are the hallmark of an innovation set to create immense human value. In this story, the innovation is cutting-edge technology for interfacing with the nervous system, and the brave early adopter is Ian Burkhart. Ian, a young…